Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / NY ARCA BIOTECH
-
Total 13F shares
-
4,343,508
-
Share change
-
-501,718
-
Total reported value
-
$647,724,445
-
Put/Call ratio
-
0%
-
Price per share
-
$149.14
-
Number of holders
-
207
-
Value change
-
-$78,443,092
-
Number of buys
-
57
-
Number of sells
-
137
Institutional Holders of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) as of Q1 2022
As of 31 Mar 2022,
FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) was held by
207 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,343,508 shares.
The largest 10 holders included
MORGAN STANLEY, WELLS FARGO & COMPANY/MN, BANK OF AMERICA CORP /DE/, UBS Group AG, Raymond James Financial Services Advisors, Inc., LPL Financial LLC, ROYAL BANK OF CANADA, Berger Financial Group, Inc, RAYMOND JAMES & ASSOCIATES, and COMMONWEALTH EQUITY SERVICES, LLC.
This page lists
210
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.